Literature DB >> 15321530

Potency and sterility of anesthetic drugs in obstetric anesthesia.

D S Wagner1, N N Naughton, C Pierson, T Michel.   

Abstract

In order to estimate how long a medication can remain prepared before the integrity or concentration of the drug is compromised, we assessed the sterility and potency of medications commonly used in our obstetric anesthesia practice. Our goal was to evaluate the following drugs over a 30-day period: epinephrine, atropine, lidocaine, succinylcholine, and ephedrine. The medications were prepared by various medical staff, drawn into sterile plastic syringes and left at room temperature unprotected from light for the duration of the study. The syringes were collected daily, stored and randomly sampled after 7, 14, 21 and 30 days by research personnel. Potency and sterility of atropine, ephedrine and lidocaine were maintained over the study period. Succinylcholine and epinephrine could not be assayed but the solutions remained sterile for 30 and 14 days respectively. Data were incomplete for epinephrine. These findings suggest that some drugs that are commonly used in obstetric anesthesia are stable for long periods of time. Modification of current standards of practice could result in a significant reduction in drug waste and therefore cost.

Entities:  

Year:  2002        PMID: 15321530     DOI: 10.1054/ijoa.2002.0983

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  2 in total

1.  Bacterial Contamination of Anaesthetic and Vasopressor Drugs in the Operating Theatres: Ameliyathanelerde Anestetik ve Vazopressör İlaçların Bakteriyel Kontaminasyonu.

Authors:  Rongrong Rueangchira-Urai; Panthila Rujirojindakul; Alan Frederick Geater; Edward McNeil
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

2.  A systematic review of epinephrine stability and sterility with storage in a syringe.

Authors:  Hannah G Parish; Jacquelyn R Morton; Julie C Brown
Journal:  Allergy Asthma Clin Immunol       Date:  2019-02-21       Impact factor: 3.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.